Literature DB >> 17179358

Transient hepatic intensity differences: part 1, Those associated with focal lesions.

Stefano Colagrande1, Nicoletta Centi, Roberta Galdiero, Alfonso Ragozzino.   

Abstract

OBJECTIVE: The purpose of our study was to evaluate, on MRI, transient hepatic signal intensity differences (THID) that have already been seen on CT as transient hepatic attenuation differences (THAD) and to show the range of appearance of such arterial phenomena, when associated with focal lesions, in an effort to correlate morphology, cause, and pathogenesis.
CONCLUSION: Hepatic arterial phenomena visualized on MRI should be known and recognized to avoid incorrect diagnoses and to improve the characterization of focal liver lesions because their shape can lead to an understanding of pathogenetic mechanisms.

Entities:  

Mesh:

Year:  2007        PMID: 17179358     DOI: 10.2214/AJR.05.1368

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  Giant area of transient hepatic attenuation difference, mimicking incidentaloma at liver ultrasound.

Authors:  Gaspare Parrinello; Daniele Torres; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2010-06-30       Impact factor: 3.397

2.  Hepatic abnormal perfusion visible by magnetic resonance imaging in acute pancreatitis.

Authors:  Wei Tang; Xiao-Ming Zhang; Zhao-Hua Zhai; Nan-Lin Zeng
Journal:  World J Radiol       Date:  2013-12-28

Review 3.  Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.

Authors:  Arman Sheybani; Ron C Gaba; R Peter Lokken; Senta M Berggruen; Winnie A Mar
Journal:  Curr Gastroenterol Rep       Date:  2017-10-18

Review 4.  Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Authors:  Matteo Renzulli; Nicolò Brandi; Giulia Argalia; Stefano Brocchi; Andrea Farolfi; Stefano Fanti; Rita Golfieri
Journal:  Radiol Med       Date:  2022-01-13       Impact factor: 3.469

5.  Transient hepatic attenuation difference (THAD) following transcatheter arterial chemoembolization for hepatic malignancy: changes on serial CT examinations.

Authors:  Sung Ho Hwang; Jeong-Sik Yu; Jin Chung; Jae-Joon Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 5.315

6.  Hepatocellular carcinoma: management of an increasingly common problem.

Authors:  Gary L Davis; Jane Dempster; James D Meler; Douglas W Orr; Mark W Walberg; Brian Brown; Brian D Berger; John K O'Connor; Robert M Goldstein
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

Review 7.  That liver lesion on MDCT in the oncology patient: is it important?

Authors:  Richard M Gore; Kiran H Thakrar; Daniel R Wenzke; Geraldine M Newmark; Uday K Mehta; Jonathan W Berlin
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

Review 8.  Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.

Authors:  Vincenza Granata; Roberta Fusco; Antonio Avallone; Orlando Catalano; Francesco Filice; Maddalena Leongito; Raffaele Palaia; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2017-04-28       Impact factor: 2.965

9.  Liver Imaging Reporting and Data System: an expert consensus statement.

Authors:  Khaled M Elsayes; Ania Z Kielar; Michelle M Agrons; Janio Szklaruk; An Tang; Mustafa R Bashir; Donald G Mitchell; Richard K Do; Kathryn J Fowler; Victoria Chernyak; Claude B Sirlin
Journal:  J Hepatocell Carcinoma       Date:  2017-02-17

10.  Arterioportal shunt incidental to treatment with oxaliplatin that mimics recurrent gastric cancer.

Authors:  Hong-Beum Kim; Sang-Gon Park
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.